Ivim Health vs Noom Med: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Visit Yucca Health - our featured pick→or find your match

Ivim Health beats Noom Med overall, scoring 7.9/10 vs 7.4/10. Noom Med is more affordable at $99/mo vs $150/mo. Choose Ivim Health for users who want personalized dosing with frequent provider ch. Choose Noom Med for users who want a tiered entry into glp-1 care, from $99/mo m.

A side-by-side look at Ivim Health and Noom Med to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Ivim Health

#8 of 52

7.9/10

Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.

Visit Ivim Health

Noom Med

#27 of 52

7.4/10

Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Feature	Ivim Health	Noom Med
Our Score	7.9/10	7.4/10
Starting Price	$150/mo	$99/mo
Medication Type	Both	Both
Insurance Accepted	No	Yes
Best For	Users who want personalized dosing with frequent provider check-ins	Users who want a tiered entry into GLP-1 care, from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program
Ranking	#8	#27
Get started	Visit Ivim Health	Visit Noom Med

Pros & Cons Compared

Ivim Health

Pros

+$75/mo starting price is among the lowest in the market for a program with actual provider oversight
+Bi-weekly provider check-ins included, more frequent than most platforms at this price point
+Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
+Both brand-name and compounded available, with the option to switch based on response

Cons

−The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses
−No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront

Noom Med

Pros

+Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+New Microdose GLP-1Rx program ($99-149/mo), low-dose GLP-1 + biomarker monitoring for sensitive users
+Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing creates confusion, $69, $99-149, or $149-349 depending on tier
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
−App coaching still requires real engagement, skip-prone users waste the behavioral value

Our Verdict

Ivim Health edges out Noom Med with a score of 7.9/10 vs 7.4/10. If budget is your priority, Noom Med starts at $99/mo compared to Ivim Health's $150/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Ivim Health if you want: users who want personalized dosing with frequent provider check-ins. Choose Noom Med if you want: users who want a tiered entry into glp-1 care, from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Ivim Health nor Noom Med feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review